We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
分析辉瑞首个血友病B基因疗法：出血减少96%，与Hemgenix竞争，以及市场隐藏风险。了解详情。
